Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice

Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice

Background: The increasing incidence and prevalence of atopic dermatitis (AD) demands new therapeutic approaches for treating the disease. We investigated the therapeutic efficacy of immunomodulator FTY720 ointment (fingolimod) for mite-induced intractable AD using an NC/Nga mouse model. Methods: Fe...

Full description

Bibliographic Details
Main Authors:	Takumi Tsuji, Satoshi Okuno, Ayano Kuroda, Junya Hamazaki, Takuma Chikami, Sakura Sakurai, Yuya Yoshida, Rie Banno, Tetsuro Fujita, Takeyuki Kohno
Format:	Article
Language:	English
Published:	Elsevier 2016-04-01
Series:	Allergology International
Subjects:	Atopic dermatitis Epidermal barrier function Filaggrin FTY720 ointment NC/Nga mice
Online Access:	http://www.sciencedirect.com/science/article/pii/S1323893015002051

Similar Items

Acute Anterior Uveitis in a Patient Taking Fingolimod (FTY720) for Multiple Sclerosis
by: Heather Gwen Mack, et al.
Published: (2016-12-01)

The Effects of the S1P Receptor Agonist Fingolimod (FTY720) on Central and Peripheral Myelin in Twitcher Mice
by: Sibylle Béchet, et al.
Published: (2024-03-01)

Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients
by: S.I. Park, et al.
Published: (2005-05-01)

The protective role of FTY720 in promoting survival of allograft fat in mice
by: Yi Yi, et al.
Published: (2022-09-01)

Fingolimod (FTY720) Preserves High Energy Phosphates and Improves Cardiac Function in Heterotopic Heart Transplantation Model
by: Naseer Ahmed, et al.
Published: (2020-09-01)

Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
by: Kathrin Bail, et al.
Published: (2017-07-01)

The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection
by: Alessandra Gonçalves Commodaro, et al.
Published: (2012-07-01)

Altered Expression of Signaling Genes in Jurkat Cells upon FTY720 Induced Apoptosis
by: Shaoheng He, et al.
Published: (2010-09-01)

Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
by: Yi Zhao, et al.
Published: (2018-07-01)

FTY720 in immuno-regenerative and wound healing technologies for muscle, epithelial and bone regeneration
by: Monica Behara, et al.
Published: (2023-05-01)

A genome-wide screen for FTY720-sensitive mutants reveals genes required for ROS homeostasis
by: Kanako Hagihara, et al.
Published: (2017-11-01)

FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis
by: Laurent Kremer, et al.
Published: (2019-03-01)

Anti-tumor drug FTY720 regulates p53-dependent transcription
by: YAO Han, XU Wen-bin, WANG Dong-lai
Published: (2021-03-01)

Synthesis of Novel FTY720 Analogs with Anticancer Activity through PP2A Activation
by: Jitendra Shrestha, et al.
Published: (2018-10-01)

FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury
by: Thomas V. Rousselle, et al.
Published: (2020-06-01)

Induction of Lysosomal Membrane Permeabilization Is a Major Event of FTY720-Mediated Non-Apoptotic Cell Death in Human Glioma Cells
by: Kyoung-jin Min, et al.
Published: (2020-11-01)

Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury
by: Raffaela Cipriani, et al.
Published: (2017-07-01)

Effect of immunomodulator, fingolimod, on ischemia reperfusion testicular injury in rats: Targeting the role of sphingolipid rheostat (fingolimod on I/R induced testicular injury)
by: Marwa N. Emam, et al.
Published: (2017-06-01)

Cardioprotective Effects of Sphingosine-1-Phosphate Receptor Immunomodulator FTY720 in a Clinically Relevant Model of Cardioplegic Arrest and Cardiopulmonary Bypass
by: Naseer Ahmed, et al.
Published: (2019-07-01)

Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy
by: Wu JY, et al.
Published: (2018-03-01)

The emerging role of FTY720 as a sphingosine 1‐phosphate analog for the treatment of ischemic stroke: The cellular and molecular mechanisms
by: Maryam Naseh, et al.
Published: (2021-06-01)

Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade
by: Janet L. Martin, et al.
Published: (2017-08-01)

FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer’s disease expressing APOE4
by: Simone M. Crivelli, et al.
Published: (2022-08-01)

Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720
by: Alessandra Roggeri, et al.
Published: (2023-09-01)

FTY720 Inhibits the Development of Collagen-Induced Arthritis in Mice by Suppressing the Recruitment of CD4+ T Lymphocytes
by: Zhu C, et al.
Published: (2021-05-01)

FTY720-P, a Biased S1PR Ligand, Increases Mitochondrial Function through STAT3 Activation in Cardiac Cells
by: Juan Pablo Muñoz, et al.
Published: (2023-04-01)

FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages
by: Koki Tachibana, et al.
Published: (2022-11-01)

Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model
by: Georgia-Ioanna Kartalou, et al.
Published: (2020-11-01)

FTY720 Inhibits Expansion of Breast Cancer Stem Cells via PP2A Activation
by: Naoya Hirata, et al.
Published: (2021-07-01)

FTY720 ameliorates GvHD by blocking T lymphocyte migration to target organs and by skin fibrosis inhibition
by: Jaeyoon Ryu, et al.
Published: (2020-06-01)

Fingolimod Modulates Dendritic Architecture in a BDNF-Dependent Manner
by: Abhisarika Patnaik, et al.
Published: (2020-04-01)

Preclinical Evaluation of Fingolimod in Rodent Models of Stroke With Age or Atherosclerosis as Comorbidities
by: Andrea C. Diaz Diaz, et al.
Published: (2022-07-01)

Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer’s Disease
by: Pablo Bascuñana, et al.
Published: (2023-02-01)

FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system
by: Felipe V. Pereira, et al.
Published: (2013-07-01)

Single-Nucleus RNA-seq of Normal-Appearing Brain Regions in Relapsing-Remitting vs. Secondary Progressive Multiple Sclerosis: Implications for the Efficacy of Fingolimod
by: Yasuyuki Kihara, et al.
Published: (2022-06-01)

Fingolimod does not prevent syndecan-4 shedding from the endothelial glycocalyx in a cultured human umbilical vein endothelial cell model of vascular injury
by: Elissa M. Milford, et al.
Published: (2022-08-01)

Fingolimod Leads to Immediate Immunological Changes Within 6 h After First Administration
by: Tony Sehr, et al.
Published: (2020-05-01)

Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod
by: Henryk Jęśko, et al.
Published: (2021-07-01)

Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K<sup>+</sup> Current and Intermediate-Conductance Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel in Jurkat T-Lymphocytes
by: Wei-Ting Chang, et al.
Published: (2020-10-01)

In silico Docking Studies of Fingolimod and S1P1 Agonists
by: Alexander Marciniak, et al.
Published: (2020-03-01)